Tags : Waters

Biosimilars

Waters Launches Peptide Multi-Attribute Method for BioAccord System to Develop

Shots: The new peptide MAM workflow for the BioAccord LC-MS system that helps to monitor critical quality attributes of protein-based drugs that can affect the safety & efficacy of innovator drugs and biosimilars By integrating BioAccord system on the waters_connect platform, scientists have a sensitive multiplexed method to accurately assess the attributes of protein-based drugs […]Read More